Teachers’ Pension seeks four managers for $177 mil PE mandate Mandate size increases from $133 mil a year ago
Translated by Ryu Ho-joung 공개 2021-07-07 07:47:41
이 기사는 2021년 07월 07일 07:43 thebell 에 표출된 기사입니다.
Teachers’ Pension, a South Korean pension scheme for private school educators, is looking for four domestic managers to award a private equity mandate totaling 200 billion won ($176.5 million).A request for proposals (RFP) issued on Monday said up to 50 billion will be committed to each manager. The mandate size increased from 150 billion won a year ago, which were awarded to three managers.
There are no constraints on investment areas and strategies. The target fund size must be greater than 300 billion won and the general partner needs to commit 1% or more of the fund size. The life of the fund cannot exceed 10 years but can be extended upon agreement between both parties. The fund’s investment period is five years from its establishment.
Only managers that have secured capital commitments worth 30% or more of the fund size from other domestic institutional investors are eligible to submit proposals. Interest firms must have more than 300 billion won in cumulative assets under management as of the RFP issue date. The firm’s key fund manager should have investing experience of more than 10 years and the firm’s head office should be domiciled in South Korea.
Proposals are due by 5 p.m. on July 23. Interviews for the shortlisted candidates and due diligence will be conducted, with the final selection expected to made before the end of August.
Last year MBK Partners, SkyLake Investment and Stonebridge Capital were each awarded 50 billion won from Teachers’ Pension.
The pension fund had approximately 21.5 trillion won in assets under management at the end of May, with exposure to alternative investments accounting for about 4.3 trillion won, or 20% of its total assets. (Reporting by Hee-yeon Han)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
best clicks
최신뉴스 in 전체기사
-
- [제일약품의 온코닉테라퓨틱 첫 '신약']세번째 P-CAB '자큐보' 2년만에 신약 명맥 잇는다
- 강동그룹, 디아너스CC 품는다
- [제약사 TSR 분석]제일약품, '주가·실적·배당' 3중고 열쇠 '온코닉의 신약'
- (여자)아이들 우기, 'YUQ1' 아이튠즈 앨범차트 10개국 석권
- 박셀바이오, 진행성 간세포암 타깃 'Vax-NK' 특허 출원
- 베니스 비엔날레, 30년만에 두발로 선 '곽훈'의 의미
- [대기업 프로스포츠 전술전략]'모기업발 숙제' 엔씨다이노스, 당분간 긴축 불가피
- 하이브, '민희진 없는' 어도어 경쟁력 입증할까
- SK 오너가 3세 최성환의 '승부수'
- 어느 수집가의 꿈 '이건희 컬렉션'